ADAM17 and cardiac hypertrophy: Considering that Nox4, a gene downstream of BRD4, is a major resource for ROS in the heart and can promote cardiac hypertrophy mediated through the Nox4/ROS/ADAM17 pathway [15, 16], the change in Nox4 protein and mRNA was analysed first.